Literature DB >> 27084788

The clinical severity score of chronic actinic dermatitis correlates with in vivo photoallergic reactions and the immunologic parameters related to a shift towards Th2 immunity from the Th2/Th1 balanced status in patients with chronic actinic dermatitis.

Dong-Yeob Ko1, Seung-Hwan Choi1, Seung-Min Ha1, Tae-Hoon Kim1, Ki-Hoon Song1, Kyeong Hee Kim2, Ki-Ho Kim1.   

Abstract

BACKGROUND: Chronic actinic dermatitis (CAD) has a more complicated pathogenetic basis than others. The clinical grading system and its correlations with the clinical and immunological parameters still remained to be investigated to define the nature of CAD in a more detailed manner.
OBJECTIVES: We investigated correlations of the clinical severity score of CAD (CSS-CAD) with the clinical and immunological parameters.
METHODS: We evaluated 72 patients with CAD and classified them into three groups according to the CSS-CAD. We analysed total IgE level, peripheral blood (PB) eosinophil count, the ratio of Th2cell (CCR4 + CD4 +) percentage over Th1 cell (CXCR3 + CD4 +) percentage (Th2/Th1) and/or the sum of suppressor/cytotoxic T cells.
RESULTS: The total IgE levels and the percentage of PB eosinophils were higher in the severer group than other groups. A shift towards Th2 from Th2/Th1 balanced status may be affected by total counts of suppressor T cells, and the patient with higher Th2/Th1 ratio than balanced status had the more proportion in the severer CSS-CAD group than other groups.
CONCLUSION: The CSS-CAD correlates with total IgE level, PB eosinophil count and a shift towards Th2 immunity from Th2/Th1. So we suggest the Th1/Th2 dysbalance may be affected by the CSS-CAD.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Th2 shift; chronic actinic dermatitis; clinical severity scores of CAD; photoallergic reactions

Mesh:

Substances:

Year:  2016        PMID: 27084788     DOI: 10.1111/phpp.12244

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  3 in total

1.  A case of chronic actinic dermatitis that responded completely to treatment with oral colostrum-macrophage-activating factor (colostrum-MAF).

Authors:  Masamitsu Ichihashi; Yoshitaka Nakamura; Masahiko Muto; Takahito Nishikata; Tosio Inui; Yoshihiro Uto
Journal:  Photodermatol Photoimmunol Photomed       Date:  2019-04-29       Impact factor: 3.135

2.  Successful Treatment of Chronic Actinic Dermatitis with Dupilumab: A Case Report and Review of the Literature.

Authors:  Jiaoquan Chen; Huaping Li; Huilan Zhu
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-12-30

3.  Clearance of Chronic Actinic Dermatitis With Dupilumab Therapy in Chinese Patients: A Case Series.

Authors:  Kamran Ali; Liming Wu; HaiYue Lou; Jianbo Zhong; YunMi Qiu; JiaYang Da; JingPeng Shan; KaiNing Lu
Journal:  Front Med (Lausanne)       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.